%0 Journal Article
%T Open-Label, Prospective Study for the Biofourmis Everion Armband Telemonitoring (BEAT) Solution for Patients during COVID-19 Home Isolation
%A Josephine Sau Fan Chow
%A Kelsey Dobell-Brown
%A Amanda Sykes
%A Sabnam Acharya Sigdel
%A Megan Collett
%J Journal of Service Science and Management
%P 168-179
%@ 1940-9907
%D 2024
%I Scientific Research Publishing
%R 10.4236/jssm.2024.172008
%X <b>Objective: </b>This study aims to assess the feasibility and suitability of the Everion Armband Device in the telemonitoring and early detection of symptoms of COVID-19-positive patients during their home isolation period. <b>Methods: </b>This is an open-label, prospective study that was conducted in 2020. Included in the study were patients diagnosed with COVID-19 and medically stable at home isolation. Eligible participants after consent were provided with the Everion Armband Device adept at recording discrete measurements such as heart rate, oxygen saturation, respiration rate, and temperature, offered a comprehensive remote monitoring solution for COVID-19 patients in their homes. Clinical data was reviewed in a timely manner by the investigator team, for post COVID-19 related symptoms, such as increase in body temperature. <b>Results:</b> Nineteen participants with a mean age of 42 years old, were recruited in the study. The temperature recorded was <35 degrees Celsius for 67% of measuring intervals on average (S.D. ± 24.13). The Armband Device provided accurate vital signs’ data. Participants reported that the device was user-friendly. While the participants responded positively to the Armband Device and monitoring process, and there was evidence that monitoring resulted in early detection of clinical deterioration, this study identified several issues that would need to be addressed to make wider use of this technology feasible and useful. <b>Conclusions: </b>The use of smart devices for remote patient monitoring, especially during a pandemic, was a novel approach that could enhance healthcare delivery and early symptom detection.
%K COVID-19
%K SARS-CoV-2
%K Vital Signs
%K Wearable Monitoring System
%K Telehealth
%K e-Health
%K Remote Patient Monitoring
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=132930